image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

UDG Healthcare - Confident CFO's unofficial target is 20% eps growth p.a.

April 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • UDG
  • Price:
  • 876p
The indiscriminate stockmarket volatility that’s raged in 2018 has thrown up some intriguing opportunities and over the month we took up the chance to speak with Alan Ralph, CFO of FTSE-250 rated UDG Healthcare, whose shares have fallen from their peak despite not putting a foot wrong.The company was originally a low margin drugs wholesale distribution business but since 2010 it has built two world class healthcare services businesses while ditching the low value bit. Larger of the two is Ashfield, a field sales business that takes over the process of promoting new drugs to physicians and medical institutions and is establishing a presence in healthcare communications such as converting scientific data into layman’s English.U ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe